Drug Shortage Report for BUSCOPAN
| Report ID | 204870 |
| Drug Identification Number | 00363812 |
| Brand name | BUSCOPAN |
| Common or Proper name | Buscopan |
| Company Name | SANOFI CONSUMER HEALTH INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYOSCINE BUTYLBROMIDE |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 20 |
| ATC code | A03BB |
| ATC description | BELLADONNAAND DERIVATIVES, PLAIN |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-09-20 |
| Estimated end date | 2023-11-24 |
| Actual end date | 2023-11-14 |
| Shortage status | Resolved |
| Updated date | 2023-11-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2905 PLACE LOUIS-R RENAUD LAVAL, QUEBEC CANADA H7V 0A3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-11-14 | French | Compare |
| v5 | 2023-11-14 | English | Compare |
| v4 | 2023-10-11 | French | Compare |
| v3 | 2023-10-11 | English | Compare |
| v2 | 2023-09-20 | French | Compare |
| v1 | 2023-09-20 | English | Compare |
Showing 1 to 6 of 6